Qube Research & Technologies LTD Pacira Bio Sciences, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 129,191 shares of PCRX stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
129,191Holding current value
$1.9 Million% of portfolio
0.01%Shares
14 transactions
Others Institutions Holding PCRX
# of Institutions
301Shares Held
51.5MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$118 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$74.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$31.8 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$30.4 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$28 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $673M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...